Equillium (EQ) Operating Leases (2021 - 2026)
Equillium (EQ) reported Operating Leases of $251000.0 for Q1 2026, up 68.46% year-over-year from $149000.0 in Q1 2025, and down 29.49% quarter-over-quarter from $356000.0 in Q4 2025.
Equillium (EQ) Operating Leases (2021 - 2026) Analysis & Trends
Equillium (EQ) has 6 years of Operating Leases data on file, last reported at $251000.0 in Q1 2026.
- Operating Leases for Q1 2026 came in at $251000.0, up 68.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $251000.0 (up 68.46% YoY), and the FY2025 annual result was $356000.0, up 90.37% from the prior year.
- Operating Leases slipped to $251000.0 in Q1 2026 per EQ's latest filing, from $356000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $1.1 million in Q1 2022 and troughed at $109000.0 in Q2 2025.
- A 5-year average of $494588.2 and a median of $384000.0 in 2023 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2024 and 2025: Operating Leases slumped 58.97% in 2024, then jumped 112.11% in 2025.
- A 5-year view of Operating Leases shows it stood at $824000.0 in 2022, then tumbled by 53.4% to $384000.0 in 2023, then plunged by 51.3% to $187000.0 in 2024, then soared by 90.37% to $356000.0 in 2025, then slipped by 29.49% to $251000.0 in 2026.
- Business Quant data shows EQ's Operating Leases at $251000.0 in Q1 2026, $356000.0 in Q4 2025, and $473000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 251,000.00 |
| Dec 31, 2025 | 356,000.00 |
| Sep 30, 2025 | 473,000.00 |
| Jun 30, 2025 | 109,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Dec 31, 2024 | 187,000.00 |
| Sep 30, 2024 | 223,000.00 |
| Jun 30, 2024 | 259,000.00 |
| Mar 31, 2024 | 295,000.00 |
| Dec 31, 2023 | 384,000.00 |
| Sep 30, 2023 | 498,000.00 |
| Jun 30, 2023 | 609,000.00 |
| Mar 31, 2023 | 719,000.00 |
| Dec 31, 2022 | 824,000.00 |
| Sep 30, 2022 | 925,000.00 |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 1.12 Mn |
| Dec 31, 2021 | 1.24 Mn |